104 results on '"Erdogan, C"'
Search Results
2. An energy-based material model for the simulation of shape memory alloys under complex boundary value problems
- Author
-
Erdogan, C., Bode, T., and Junker, P.
- Subjects
Computer Science - Computational Engineering, Finance, and Science - Abstract
Shape memory alloys are remarkable 'smart' materials used in a broad spectrum of applications, ranging from aerospace to robotics, thanks to their unique thermomechanical coupling capabilities. Given the complex properties of shape memory alloys, which are largely influenced by thermal and mechanical loads, as well as their loading history, predicting their behavior can be challenging. Consequently, there exists a pronounced demand for an efficient material model to simulate the behavior of these alloys. This paper introduces a material model rooted in Hamilton's principle. The key advantages of the presented material model encompass a more accurate depiction of the internal variable evolution and heightened robustness. As such, the proposed material model signifies an advancement in the realistic and efficient simulation of shape memory alloys.
- Published
- 2024
3. The bisbenzothiazole-p-tert-butylcalix[4]arene-thiourea Langmuir–Blodgett thin films: preparation, optical properties, swelling dynamics and gas sensing properties via host–guest principles
- Author
-
Bozkurt, S., Durmaz, M., Erdogan, M., Ozkaya Erdogan, C., Capan, R., and Acikbas, Y.
- Published
- 2022
- Full Text
- View/download PDF
4. Opacification of nondilated bile ducts through the gallbladder as an aid to percutaneous transhepatic biliary drainage
- Author
-
Ozturk, K., Nas, O.F., Soylu, E., Hacikurt, K., and Erdogan, C.
- Published
- 2018
- Full Text
- View/download PDF
5. Stability analysis of roadheaders with mini-disc
- Author
-
Acaroglu, O. and Erdogan, C.
- Published
- 2017
- Full Text
- View/download PDF
6. A comparative study of art therapy in cancer patients receiving chemotherapy and improvement in quality of life by watercolor painting
- Author
-
Bozcuk, H., Ozcan, K., Erdogan, C., Mutlu, H., Demir, M., and Coskun, S.
- Published
- 2017
- Full Text
- View/download PDF
7. Effectiveness of percutaneous vertebroplasty in cases of vertebral metastases
- Author
-
Nas, O.F., Inecikli, M.F., Kacar, E., Buyukkaya, R., Ozkaya, G., Aydın, O., Erdogan, C., and Hakyemez, B.
- Published
- 2015
- Full Text
- View/download PDF
8. Role of TRPC6 in Kidney Damage after Acute Ischemic Kidney Injury
- Author
-
Zheng, Z., Tsvetkov, D., Bartolomaeus, T., Erdogan, C., Krügel, U., Schleifenbaum, J., Schaefer, M., Nürnberg, B., Chai, X., (0000-0002-4358-5171) Ludwig, F.-A., Ndiaye, G., Köhler, M.-B., Wu, K., Gollasch, M., Markó, L., Zheng, Z., Tsvetkov, D., Bartolomaeus, T., Erdogan, C., Krügel, U., Schleifenbaum, J., Schaefer, M., Nürnberg, B., Chai, X., (0000-0002-4358-5171) Ludwig, F.-A., Ndiaye, G., Köhler, M.-B., Wu, K., Gollasch, M., and Markó, L.
- Abstract
Transient receptor potential channel subfamily C, member 6 (TRPC6), a non-selective cation channel that controls influx of Ca2+ and other monovalent cations into cells, is widely expressed in the kidney. TRPC6 gene variations have been linked to chronic kidney disease but its role in acute kidney injury (AKI) is unknown. Here we aimed to investigate the putative role of TRPC6 channels in AKI. We used Trpc6−/− mice and pharmacological blockade (SH045 and BI-749327), to evaluate short-term AKI outcomes. Here, we demonstrate that neither Trpc6 deficiency nor pharmacological inhibition of TRPC6 influences the short-term outcomes of AKI. Serum markers, renal expression of epithelial damage markers, tubular injury, and renal inflammatory response assessed by the histological analysis were similar in wild-type mice compared to Trpc6−/− mice as well as in vehicle-treated versus SH045- or BI-749327-treated mice. In addition, we also found no effect of TRPC6 modulation on renal arterial myogenic tone by using blockers to perfuse isolated kidneys. Therefore, we conclude that TRPC6 does not play a role in the acute phase of AKI. Our results may have clinical implications for safety and health of humans with TRPC6 gene variations, with respect to mutated TRPC6 channels in the response of the kidney to acute ischemic stimuli.
- Published
- 2022
9. P622 Comparison of long-term outcomes of infliximab and adalimumab in biologic-naïve patients with ulcerative colitis
- Author
-
Durak, M B, primary, Baspınar, B, additional, Guven, I E, additional, Kivrakoglu, F, additional, Kilic, V, additional, Kosar, K, additional, Erdogan, C, additional, and Yüksel, I, additional
- Published
- 2022
- Full Text
- View/download PDF
10. P536 Comparison of outcomes of infliximab biosimilar CT-P13 with infliximab originator in patients with inflammatory bowel disease
- Author
-
Yüksel, I, primary, Baspınar, B, additional, Durak, M B, additional, Kilic, V, additional, Kivrakoglu, F, additional, Guven, I E, additional, Kosar, K, additional, Erdogan, C, additional, and Alkan, A, additional
- Published
- 2022
- Full Text
- View/download PDF
11. Die Rolle des TRPC6 Kanals im Rahmen der akuten Nierenschädigung
- Author
-
Zheng, Z., Tsvetkov, D., Bartolomaeus, T. U. P., Erdogan, C., Krügel, U., Schleifenbaum, J., Schaefer, M., Nürnberg, B., Chai, X., (0000-0002-4358-5171) Ludwig, F.-A., N’Diaye, G., Köhler, M.-B., Wu, K., Gollasch, M., Marko, L., Zheng, Z., Tsvetkov, D., Bartolomaeus, T. U. P., Erdogan, C., Krügel, U., Schleifenbaum, J., Schaefer, M., Nürnberg, B., Chai, X., (0000-0002-4358-5171) Ludwig, F.-A., N’Diaye, G., Köhler, M.-B., Wu, K., Gollasch, M., and Marko, L.
- Abstract
Aims: Transient receptor potential (TRP) channels are non-selective cation channels that promote influx of Ca2+, Mg2+ and monovalent cations into cells. TRP channel subfamily C, member 6 (TRPC6) is widely expressed - next to several other tissues - in the kidney, and gene variations were linked to fibrosing renal disease. Here we aimed to investigate the putative role of TRPC6 channels in acute kidney injury (AKI). Since ischemia/reperfusion injury is known relate to Ca2+ overload, we hypothesized that inhibition of TRPC6 ameliorates AKI. Methods: We used Trpc6-/- mice and SH045, a pharmacological inhibitor of TRPC6, to evaluate short-term AKI outcomes. Ischemia was induced after right–sided nephrectomy by clipping the renal pedicle of the left kidney for 20 or 17.5 minutes. SH045 was used for intravenous injection (2 mg/kg) 30 minutes before I/R surgery in the pharmacological studies with WT mice. Results: Here, we demonstrate that neither Trpc6 deficiency nor pharmacological inhibition of TRPC6 influence the short-term outcomes of AKI. Blood markers (Creatinine in WT [131.4±33.3 µmol/l] vs Trpc6-/- [159.6±41.7 µmol/l] mice after 24 hours of reperfusion and in the pharmacological study: 17.5 min-I/R vehicle [199.5±21.8 µmol/l] versus 17.5 min-I/R SH045 [172.6±31.6 µmol/l], and 20 min-I/R vehicle [212.2±8.4 µmol/l] versus 20 min-I/R SH045 [226.2±28.6 µmol/l], all comparisons are n.s.), renal expression of epithelial damage markers, tubular injury and renal inflammatory response assessed by histological analysis were similar in wild-type mice compared to Trpc6-/- mice as well as in vehicle-treated versus SH045-treated mice. In addition, our results also found no effect of TRPC6 modulation on renal myogenic tone by using SH045 to perfuse isolated kidneys. Conclusion: Therefore, we conclude that TRPC6 does not play role on the acute phase of AKI. Further studies should focus if TRPC6 inhibition could be protective in terms of long-term outcome of an AKI.
- Published
- 2021
12. P563 Comparison of long-term outcomes of infliximab with adalimumab in biologic naïve patients with Crohn’s disease: a tertiary referral center 13-year experience
- Author
-
Yuksel, I, primary, Durak, M B, additional, Kilic, V, additional, Kivrakoglu, F, additional, Kosar, K, additional, Erdogan, C, additional, and Alkan, A, additional
- Published
- 2021
- Full Text
- View/download PDF
13. care unit: A randomised controlled trial
- Author
-
Erdogan, C, Turan, T, and Pinar, B
- Subjects
Paediatric intensive care unit ,Nurses ,Pain management ,Maternal voice - Abstract
Objective: The aim of this study was to evaluate the effectiveness of the maternal voice in reducing pain during painful procedures in children between one and three years old receiving treatment in paediatric intensive care unit. Design and methods: This research was designed as a randomised controlled experimental study. Sixty children were randomised into two groups, the maternal-voice group and the controls. The children in the maternal-voice group listened to the maternal voice during the procedure. Although questionnaire forms were used to determine the descriptive characteristics of infants, the Face, Legs, Activity, Cry, Consolability (FLACC) pain assessment scale was used to evaluate pain level. Heart rate and oxygen saturation were also measured. Results: There were significant differences in the pain, heart rate and oxygen saturation levels between the maternal-voice and control groups. Pain levels and heart rates of the children in the experimental group during and after the painful procedures were much lower, and their oxygen saturations were higher than those of the children in the control group. Practic implications: Distraction methods, such as listening to the maternal voice, should be used as a nursing intervention to reduce pain and decrease heart rate and increaseoxygen saturation in children during painful procedures in the paediatric intensive care unit. The maternal voice is recommended as a helpful option in cases when a pain control method is required. Future research needs to explore different interventional practices. (C) 2019 Elsevier Ltd. All rights reserved. C1 [Erdogan, Cigdem; Turan, Turkan] Pamukkale Univ, Fac Hlth Sci, Pediat Nursing Dept, Denizli, Turkey. [Pinar, Bakiye] Pamukkale Univ, Pamukkale Univ Hosp, Pediat Intens Care Unit, Denizli, Turkey.
- Published
- 2020
14. support scale: Neonatal intensive care unit
- Author
-
Turan, T, Erdogan, C, and Ceylan, SS
- Subjects
Parents ,Support ,Fathers ,Neonatal intensive care unit ,Infants - Abstract
Background: Fathers whose infants are cared for in the neonatal intensive care unit have negative experiences and thus require support. Aim: This study was carried out with the aim of performing a validity and reliability study of the Turkish version of the "Father's Support Scale: Neonatal Intensive Care Unit" (FSS: NICU). Method: The study included 165 fathers whose infants were hospitalised in the neonatal intensive care units of a university hospital and a state hospital in the west of Turkey. Findings: The item-total score correlation values of the scale were between 0.26 and 0.73 and the Cronbach's alpha coefficient was 0.91. It was found out that the test-retest reliability coefficients were between 0.78 and 0.92. The scale accounted for 48.38% of the total variance in three factors, as in the original version of the scale. Conclusion: It was found that the Turkish version of the FSS: NICU was a valid and reliable measurement tool. (C) 2018 Elsevier Ltd. All rights reserved. C1 [Turan, Turkan; Erdogan, Cigdem; Ceylan, Sibel Serap] Pamukkale Univ, Pediat Nursing Dept, Fac Hlth Sci, Denizli, Turkey.
- Published
- 2019
15. Turkey
- Author
-
Gokyigit, MC, Ekmekci, H, Durmus, H, Karll, N, Koseoglu, E, Aysal, F, Kotan, D, Ali, A, Koytak, PK, Karasoy, H, Yaman, A, Sengun, IS, Sayin, R, Tiftikcioglu, BI, Soysal, A, Tutkavul, K, Bayrak, AO, Kisabay, A, Elci, MA, Yayla, V, Yilmaz, IA, Ozdamar, SE, Erdogan, C, Tasdemir, N, and Oflazer, PS
- Subjects
LOPD ,Registry ,Limb girdle muscle weakness ,Acid alpha glucosidase - Abstract
The aim of this study was to search for the frequency of late onset Pompe disease (LOPD) among patients who had a myopathy with unknown diagnosis registered in the pre-diagnostic part of a novel registry for LOPD within a collaborative study of neurologists working throughout Turkey. Included in the study were 350 patients older than 18 years who have a myopathic syndrome without a proven diagnosis by serum creatine kinase (CK) levels, electrodiagnostic studies, and/or muscle pathology, and/or genetic tests for myopathies other than LOPD. Acid alpha glucosidase (GAA) in dried blood spot was measured in each patient at two different university laboratories. LOPD was confirmed by mutation analysis in patients with decreased GAA levels from either both or one of the laboratories. Pre-diagnostic data, recorded by 45 investigators from 32 centers on 350 patients revealed low GAA levels in a total of 21 patients; from both laboratories in 6 and from either one of the laboratories in 15. Among them, genetic testing proved LOPD in 3 of 6 patients and 1 of 15 patients with decreased GAA levels from both or one of the laboratories respectively. Registry was transferred to Turkish Neurological Association after completion of the study for possible future use and development. Our collaborative study enabled collection of a considerable amount of data on the registry in a short time. GAA levels by dried blood spot even from two different laboratories in the same patient may not prove LOPD. LOPD seemed to be rarer in Turkey than in Europe. (C) 2017 Elsevier B.V. All rights reserved.
- Published
- 2018
16. in Turkey
- Author
-
Erdogan, C and Turan, T
- Subjects
Infant care ,Risk factors ,Sudden infant death syndrome ,Nursing - Abstract
Purpose: Sudden infant death syndrome is the most common cause of death during the post-neonatal period. Factors such as sleeping position, bed sharing, pillow use, smoking during pregnancy and the breastfeeding period constitute risk factors for sudden infant death syndrome. This study aims to identify the risky behaviors of mothers with infants that may put their children at risk for sudden infant death syndrome. Design and methods: This is a cross-sectional, descriptive study. Data were collected using a questionnaire that was developed by the researchers. The questionnaire was filled out by 456 mothers who applied to the family health center between October 2014 and January 2015. Results: The greatest risk factor is the infant's sleeping position. A total of 77.9% of the mothers put their babies in bed in a non-supine position; 65.8% used a pillow when they put their babies in bed, 52.9% used a soft mattress, and 28.5% shared their beds with their babies. Prone sleeping was more likely to occur when smokewas present in the home or a pillow was used. Conclusion: Nurses should notify families of the risky behaviors that can cause sudden infant death syndromeand plan appropriate nursing care. (c) 2017 Elsevier Inc. All rights reserved.
- Published
- 2018
17. WHAT IS THE REAL EFFECT OF PREGABALIN IN PATIENTS WITH DIABETIC
- Author
-
Erdogan, C, Ongun, N, Tumkaya, S, Alkan, H, and Ozturk, N
- Subjects
pregabalin ,diabetic neuropathic pain ,anxiety ,depression - Abstract
Objectives - Depression and anxiety are frequent in patients with chronic diseases such as diabetic neuropathic pain. The pain seems to be more severe in patients in whom depressive findings accompanied pain symptoms. Pregabalin was reported to have positive effects on anxiety and depression. This brings out the question, whether the pain relief effect of pregabalin is due to its analgesic effect or to its effects on mood? The aim of this study is to find out whether the positive effect of pregabalin in patients with diabetic neuropathic pain is limited to its effect on pain. Thus the question do patients suffer from less pain or do they less care about pain? should be answered. Methods - With this aim the NRS scores of 46 patients with diabetic neuropathic pain, whose HADS scores did not change with pregabalin treatment were compared with their baseline levels, retrospectively. Results - The NRS scores of the group were reduced with pregabalin treatment. Conclusion - This results suggests that the reduced pain in pregabalin treatment should be independent from its effects on depression and anxiety.
- Published
- 2018
18. Nationwide Study
- Author
-
Tuncer, T, Gilgil, E, Kacar, C, Kurtais, Y, Kutlay, S, Butun, B, Yalcin, P, Akarirmak, U, Altan, L, Ardic, F, Ardicoglu, O, Altay, Z, Canturk, F, Cerrahoglu, L, Cevik, R, Demir, H, Durmaz, B, Dursun, N, Duruoz, T, Erdogan, C, Evcik, D, Gursoy, S, Hizmetli, S, Kaptanoglu, E, Kayhan, O, Kirnap, M, Kokino, S, Kozanoglu, E, Kuran, B, Nas, K, Oncel, S, Sindel, D, Orkun, S, Sarpel, T, Savas, S, Sendur, OF, Senel, K, Ugurlu, H, Uzunca, K, Tekeoglu, I, and Guillemin, F
- Subjects
Epidemiology ,prevalence ,rheumatoid arthritis ,spondyloarthritis - Abstract
Objectives: This study aims to estimate the prevalence of rheumatoid arthritis (RA) and spondyloarthritis (SpA) in Turkey using the same telephone questionnaire developed for screening RA and SpA in France and used in Serbia and Lithuania. Material and methods: The study was performed in two steps. In step I, the French questionnaire was translated into Turkish and validated through a group of 200 patients (80 males, 120 females; mean age 44.0 +/- 13.1 years; range, 19 to 75 years) followed up at the rheumatology departments of University Hospitals in Antalya and Ankara. In step II, the validated Turkish questionnaire was administered face-to-face to randomly selected 4,012 subjects (1,670 males, 2,342 females; mean age 41.5 +/- 16.8 years; range, 16 to 97 years) by trained general practitioners across the country, in 25 provinces for case detection. The subjects who were suspected of having RA or SpA in accordance with the questionnaire were invited to the nearest university hospital for rheumatologic examination in order to confirm the diagnosis. Results: In step II, a total of 25 subjects (2 males, 23 females) were diagnosed as RA. The standardized RA prevalence for the general population of Turkey was calculated as 0.56% (95% confidence interval [CI]; 0.33-0.79), 0.10% (95% CI; -0.05-0.25) for males and 0.89% (95% CI; 0.51-1.27) for females. A total of 18 subjects (3 males, 15 females) were diagnosed as SpA. The standardized SpA prevalence for the general population of Turkey was 0.46% (95% CI; 0.25-0.67), 0.17% (95% CI; -0.03-0.37) for males and 0.65% (95% CI; 0.32-0.98) for females. The prevalence of RA was highest in the Northern region (2.00%) and the prevalence of SpA was highest in the Central region (1.49%). Conclusion: The prevalences of RA and SpA in Turkey are close to each other and there are significant inter-regional variations in prevalences of both RA and SpA.
- Published
- 2018
19. Torsade de Pointes during placement of an implantable cardioverter-defibrillator in a child with long QT syndrome
- Author
-
Gökay B.V., Karaaslan P., Erdogan C., Özyüksel K., Özyüksel A., Gökay, B.V., Department of Anesthesiology and Reanimation, Acibadem University Atakent Hospital, Istanbul, Turkey, Karaaslan, P., Department of Anesthesiology and Reanimation, Istanbul Medipol University Hospital, Istanbul, Turkey, Erdogan, C., Department of Anesthesiology and Reanimation, Istanbul Medipol University Hospital, Istanbul, Turkey, Özyüksel, K., Department of Anesthesiology and Reanimation, Istanbul Medipol University Hospital, Istanbul, Turkey, and Özyüksel, A., Department of Cardiovascular Surgery, Istanbul Medipol University Hospital, Istanbul, Turkey
- Subjects
Sevoflurane ,Long QT syndrome ,Arrhythmia - Abstract
Long QT syndrome is characterized by a prolongation of the QT interval resulting in a tendency to ventricular tachyarrhythmias, particularly Torsade de Pointes. Inhalational anesthetics are often accused of prolonged QT interval. Herein, we report a pediatric case of long QT syndrome with a persistent Torsade de Pointes episode under general anesthesia with sevoflurane during surgical implantable cardioverter-defibrillator placement. Recurrent Torsade de Pointes requiring electrical cardioversion were considered to be unrelated to the surgical management. These episodes were considered to be related to sevoflurane inhalation. After terminating sevoflurane, arrhythmias disappeared. As malignant arrhythmias may have detrimental results for patients, we conclude that inhalation anesthetics should be avoided in patients with long QT syndrome.
- Published
- 2016
20. Use of Solitaire™ retrievable stent-assisted coiling technique for endovascular treatment of post-traumatic direct carotid cavernous fistula
- Author
-
Fatih Nas, O., Buyukkaya, R., Kacar, E., Erdogan, C., and Hakyemez, B.
- Published
- 2016
- Full Text
- View/download PDF
21. Retrieval of a dislocated coil and stent-assisted coiling by Solitaire® stent during endovascular treatment of an intracranial aneurysm
- Author
-
Nas, O.F., Kacar, E., Kaya, A., Erdogan, C., and Hakyemez, B.
- Published
- 2016
- Full Text
- View/download PDF
22. awareness and impact on the quality of life
- Author
-
Yildiz, N, Akkoc, Y, Ersoz, M, Gunduz, B, Erhan, B, Yesil, H, Bardak, AN, Ozdolap, S, Tunc, H, Koklu, K, Alemdaroglu, E, Erden, E, Sungur, U, Satir, O, Erdogan, C, and Alkan, H
- Subjects
Urinary problems ,Cerebral palsy ,Functional status ,Quality of life - Abstract
We aimed to assess the functional status, urinary problems, and awareness of these problems in adults with cerebral palsy (CP) and their relationship with the quality of life. One-hundred-seventeen adults with CP (53 women, 64 men) were included in this study. Subjects were asked to fill out a urological questionnaire which dealt with urinary symptoms, awareness of urinary problems, and pharmacological treatment they received. Subjects were also assessed with the Gross Motor Function Classification System (GMFCS), Functional Independence Measures (FIM), Functional Mobility Scale (FMS), and King's Health Questionnaire (KHQ). The mean age of the subjects was 25.3 +/- 7.8 years. Of the patients, 83.8% were currently unemployed, 95.7% were single, and 96.5% were living with family. Of the patients, 20.5% had experienced frequency, 38.5% had nocturia, 48.7% had urgency, and 36.8% had urge urinary incontinence. Approximately 80% of the patients did not refer to physician due to urinary problems, and 60% of patients were not recorded history about urinary problem by any physician. Urge urinary incontinence was statistically more frequent in females than males (54.7 and 21.9%,respectively, p < 0.05). Female patients had significantly higher KHQ incontinence impact, role limitation, physical limitation, emotion, incontinence severity measures, and symptom severity subgroup scores than male patients (p < 0.05). Urge urinary incontinence was most frequent (65.4%) in spastic quadriplegic CP (p < 0.05). All functional status scores (GMFCS, FIM-toilet transfer, and FMSs) were worse in spastic quadriplegic patients than other topographical involvement of CP (p < 0.0125). Although the urinary problems are common in adult with CP, it is yet an overlooked condition that could affect quality of life. Therefore, health care professionals, patients, and their caregivers should be aware of the increased risk of urinary problems in these patients.
- Published
- 2017
23. All-Trans Retinoic Acid Syndrome (ATRA) : A Case Report
- Author
-
Odabasi, Gamze, Aksoy, N., Kizilaslan, D., and Erdogan, C.
- Abstract
Introduction:Acute myeloid leukemia (AML) is a hematological malignancy associated with life-threatening coagulopathy.All trans retinoic acid (ATRA) therapy is one of the treatment approaches of AML M3. Acute respiratory failuremay occur in patients receiving ATRA therapy, which require close monitoring for respiratory function inpatients receiving this medication.A 34 year old female admitted to intensive care unit with dsypnea. The patient have previous history of AMLM3. After first ATRA treatment, she suffered from hypoxia, respiratory failure and transfered to the intensivecare unit (ICU). Hemodialysis and plasmapheresis were applied alternately during the treatment for cytokineremoval. Mechanical ventilation and drug therapy were started.The patient's hemoglobin, Oxygen saturation and blood pressure returned to normal after mechanicalventilation support, antihypertensive therapy, nutritional support with Total Parenteral Nutrition, antibiotictherapy and erythrocyte suspension replacement therapy for low hemoglobin and hematocrit level.It should be considered that ATRA can cause respiratory problem such as life-threating Acute RespiratoryDistress Syndrome. Close monitoring and respiratory assessment must be done. Early intervention anddiscontinuation of ATRA may be life saving in this group of patients.
- Published
- 2017
24. Rare use of Atrieve Vascular Snare™ for percutaneous transcatheter retrieval of central venous port catheter fragments
- Author
-
Nas, O.F., Kacar, E., Dogan, N., Atasoy, M.M., and Erdogan, C.
- Published
- 2015
- Full Text
- View/download PDF
25. Intracranial aneurysm rupture during flow diverter stent placement: Successful treatment with stent-in-stent combination
- Author
-
Kacar, E., Fatih Nas, O., Erdogan, C., and Hakyemez, B.
- Published
- 2015
- Full Text
- View/download PDF
26. The evaluation of phenytoin treatment according to the corrected phenytoin levels
- Author
-
Kocberber, E. K., Ceylan, C., Kizilaslan, D., Erdogan, C., and Barkin Berk
- Subjects
Pharmacology ,Pharmacy ,Phenytoin Levels - Abstract
WOS: 000384561800053 …
- Published
- 2016
27. Obesity
- Author
-
Fidan-Yaylali, G, Yaylali, YT, Erdogan, C, Can, B, Senol, H, Gedik-Topcu, B, and Topsakal, S
- Subjects
Epicardial fat thickness ,Waist circumference ,Body mass index ,Autonomic nervous system - Abstract
Objective: To determine the relationship between central adiposity parameters and autonomic nervous system (ANS) dysfunction. Subjects and Methods: The study included 114 obese individuals without any cardiovascular risk factors. Weight (in kg), height (in m), and waist circumference (WC; in cm) were measured and body mass index was calculated. Echocardiographic examination was performed to measure left ventricular mass and epicardial fat thickness (EFT). All the participants underwent an exercise test and electrophysio-logical evaluation using electromyography. Heart rate recovery (HRR) at 1-5 min, R-R interval variation at rest and during hyperventilation, and sympathetic skin response were measured. Pearson's correlation analysis was used. Multiple linear regression analysis was used to identify the factors associated with autonomic dysfunction. Results: The HRR at 1-5 min was negatively correlated with WC and age (WC-HRR1: r = -0.32; WC-HRR2: r = -0.31; WC-HRR3: r = -0.26; WC-HRR4: r = -0.23; WC-HRR5: r = -0.21; age-HRR2: r = -0.32; age-HRR3: r = -0.28; age-HRR4: r = -0.41; age-HRR5: r = -0.42). Age was the only independent predictor of reduced HRR at 1-5 min. In addition, WC predicted a reduced HRR at 3 min. There were no significant associations between central obesity and electrophysiological parameters. EFT was not associated with ANS dysfunction. Conclusion: In this study, central adiposity and aging were associated with ANS dysfunction in obese individuals. The WC could be a marker of ANS dysfunction in obese individuals without any cardiovascular risk factors. The HRR assessment at a later decay phase could be more valuable for evaluating ANS function than during early recovery. (C) 2016 S. Karger AG, Basel
- Published
- 2016
28. Fahr's syndrome presenting with epileptic seizure: Two case reports
- Author
-
Ongun N, Degirmenci E, and Erdogan C
- Abstract
Fahr's syndrome is a neuropsychiatric syndrome characterized by symmetrical and bilateral intracerebral calcifications located in the basal ganglia and usually associated with a phosphorus and calcium metabolism disorder. Clinical manifestations of Fahr's syndrome vary; it may start at different ages and have a variety of presentations. This article discusses rare presentation of Fahr's syndrome with epileptic seizure. These cases are important because they appear to be the first cases in the literature of Fahr's syndrome presenting with generalized tonic clonic seizure.
- Published
- 2016
29. Proof of concept for satellite attitude determination using GNSS
- Author
-
Metehan Yurt, Noyan Evirgen, Burak Akbulut, Cent Tansu, Ozgur C. Sakinci, Erdogan C. Unlusoy, and Arda Sen
- Subjects
GNSS augmentation ,business.industry ,Computer science ,RSS ,Real-time computing ,computer.file_format ,Physics::Geophysics ,Signal-to-noise ratio ,Proof of concept ,GNSS applications ,Physics::Space Physics ,Global Positioning System ,Satellite navigation ,Satellite ,business ,computer ,Remote sensing - Abstract
This paper introduces the proof of concept of low-Earth-orbit satellite attitude determination using GNSS, mainly GPS satellite signals. Two methods are considered and compared in detail: carrier phase measurements and signal-to-noise ratio (SNR-RSS) method. A preliminary design to be used in testing the algorithms is explained, and results of simulations with RSS method are presented.
- Published
- 2015
- Full Text
- View/download PDF
30. SUN-P194: Conservative Treatment of Chylothorax During Pregnancy
- Author
-
Görek Dilektaşlı, A., primary, Aydın Güçlü, Ö., additional, Demirdogen Cetinoglu, E., additional, Acet Ozturk, N., additional, Ursavas, A., additional, Erdogan, C., additional, Karadag, M., additional, and Uzaslan, E., additional
- Published
- 2016
- Full Text
- View/download PDF
31. SUN-LB001: The Role of Nutritional Status in Parkinson’s Disease Patients and its Effects on Quality of Life
- Author
-
Ongun, N., primary, Erdogan, C., additional, Degirmenci, E., additional, and Bir, L.S., additional
- Published
- 2015
- Full Text
- View/download PDF
32. Proof of concept for satellite attitude determination using GNSS
- Author
-
Sen, Arda, primary, Tansu, Cem, additional, Unlusoy, Erdogan C., additional, Yurt, Metehan, additional, Evirgen, Noyan, additional, Sakinci, Ozgur C., additional, and Akbulut, Burak, additional
- Published
- 2015
- Full Text
- View/download PDF
33. A database for screening and registering late onset Pompe disease in Turkey
- Author
-
Gokyigit, M.C., Ekmekci, H., Durmus, H., Karlı, N., Koseoglu, E., Aysal, F., Kotan, D., Ali, A., Koytak, P.K., Karasoy, H., Yaman, A., Sengun, İ.S., Sayin, R., Tiftikcioglu, B.I., Soysal, A., Tutkavul, K., Bayrak, A.O., Kısabay, A., Elci, M.A., Yayla, V., Yılmaz, İ.A., Ozdamar, S.E., Erdoğan, Çağdaş, Tasdemir, N., Serdaroglu Oflazer, P., Deymeer, F., Parman, Y., Kendirci, M., Sayan, S., Celebi, L.G., Uluç, K., Tanrıdağ, T., Yuceyar, N., Ekmekci, O., Colakoglu, B.D., Ozturk, S., Tireli, H., Selcuki, D., Neyal, A.M., Kayran, Y., Aluclu, M.U., Koyuncuoglu, H.R., Tokucoglu, F., Secil, Y., Guney, F., Gozke, E., Balaban, H., Akalın, M.A., Koc, A.F., Mulayim, S., Turgut, N., Turkish Study Group for Late Onset Pompe Disease, Gokyigit, Munevver Celik Sisli Hamidiye Etfal Ed Res Hosp, Dept Neurol, Istanbul, Turkey, Ekmekci, Hakan Selcuk Univ Hosp, Dept Neurol, Konya, Turkey, Durmus, Hacer, Oflazer, Piraye Serdaroglu Istanbul Univ, Istanbul Fac Med, Dept Neurol Istanbul, Istanbul, Turkey, Karll, Necdet Uludag Univ Hosp, Dept Neurol, Bursa, Turkey, Koseoglu, Emel Erciyes Univ Hosp, Dept Neurol, Kayseri, Turkey, Aysal, Fikret Medipol Univ Hosp, Istanbul, Turkey, Kotan, Dilcan Sakarya Univ Hosp, Dept Neurol, Sakarya, Turkey, Ali, Asuman Sevket Yilnzaz Res Hosp, Dept Neurol, Bursa, Turkey, Koytak, Pinar Kahraman Marmara Univ Hosp, Dept Neurol, Istanbul, Turkey, Karasoy, Hatice Ege Univ Hosp, Dept Neurol, Izmir, Turkey, Yaman, Aylin Antalya Ed Res Hosp, Dept Neurol, Antalya, Turkey, Sengun, Ihsan Sukru Dokuz Eylul Univ Hosp, Dept Neurol, Izmir, Turkey, Sayin, Refah Yuzuncu Yil Univ Hosp, Dept Neurol, Van, Turkey, Tiftikcioglu, Bedile Irem Tepecik Ed Res Hosp, Izmir, Turkey, Soysal, Aysun Balarkoy Psychiat & Neurol Hosp, Dept Neurol, Istanbul, Turkey, Tutkavul, Kemal Haydarpa Ed Res Hosp, Dept Neurol, Istanbul, Turkey, Bayrak, Ayse Oytun Ondokuz Maps Univ Hosp, Dept Neurol, Samsun, Turkey, Kisabay, Aysin Celal Bayar Univ Hosp, Dept Neurol Manisa, Manisa, Turkey, Elci, Mehmet Ali Gaziantep Univ Hosp, Dept Neurol Gaziantep, Gaziantep, Turkey, Yayla, Vildan Balarkoy Sadi Konuk Ed Res Hosp, Dept Neurol, Istanbul, Turkey, Yilmaz, Ibrahim Arda Mersin Univ Hosp, Dept Neurol, Mersin, Turkey, Ozdamar, Sevim Erdem Hacettepe Univ Hosp, Dept Neurol, Ankara, Turkey, Erdogan, Cagdas Pamukkale Univ Hosp, Dept Neurol, Denizli, Turkey, Tasdemir, Nebahat Dicle Univ Hosp, Dept Neurol, Diyarbakir, Turkey, Gokyigit, Munevver Celik Beykent Univ, Istanbul, Turkey, Gokyigit, Munevver Celik -- 0000-0002-3395-3460, Uluc, Kayihan -- 0000-0001-6132-2300, Piraye -- 0000-0001-8202-5313, Ekmekci, Hakan -- 0000-0002-5605-2980, Dept. of Neurology, Sisli Hamidiye Etfal Ed. Res. Hosp., Istanbul, Turkey, Dept. of Neurology, Selçuk University Hosp., Konya, Turkey, Dept. of Neurology Istanbul, İstanbul Medical Faculty, University of Istanbul, Istanbul, Turkey, Dept. of Neurology, Uludağ University Hosp., Bursa, Turkey, Dept. of Neurology, Erciyes University Hosp., Kayseri, Turkey, Medipol University Hosp., Istanbul, Turkey, Dept. of Neurology, Sakarya University Hosp., Sakarya, Turkey, Dept. of Neurology, Sevket Yılmaz Ed. Res. Hosp., Bursa, Turkey, Dept. of Neurology, Marmara University Hospital, Istanbul, Turkey, Dept. of Neurology, Ege University Hosp., İzmir, Turkey, Dept. of Neurology, Antalya Ed. Res. Hosp., Antalya, Turkey, Dept. of Neurology, Dokuz Eylül University Hosp., İzmir, Turkey, Dept. of Neurology, Yüzüncü Yil University Hospital, Van, Turkey, Tepecik Ed. Res. Hosp., Izmir, Turkey, Dept. of Neurology, Bakırkoy Psychiatric and Neurological Hosp., Istanbul, Turkey, Dept. of Neurology, Haydarpaşa Ed. Res. Hosp., İstanbul, Turkey, Dept. of Neurology, Ondokuz Mayıs University Hosp., Samsun, Turkey, Dept. of Neurology Manisa, Celal Bayar University Hosp., Manisa, Turkey, Dept. of Neurology Gaziantep, Gaziantep University Hosp., Gaziantep, Turkey, Dept. of Neurology, Bakırkoy Sadi Konuk Ed. Res. Hosp., Istanbul, Turkey, Dept. of Neurology, Mersin University Hosp., Mersin, Turkey, Dept. of Neurology, Hacettepe University Hosp., Ankara, Turkey, Dept. of Neurology, Pamukkale University Hosp., Denizli, Turkey, Dept. of Neurology, Dicle University Hosp., Diyarbakır, Turkey, Istanbul Medical Faculty, Dept. of Neurology, University of Istanbul, Istanbul, Turkey, Dept. of Neurology, Ege University Hosp., Izmir, Turkey, Dept. of Neurology, Dokuz Eylul University Hosp., Izmir, Turkey, Dept. of Neurology, Selcuk University Hospital, Konya, Turkey, Dept. of Neurology, Haydarpasa Ed. Res. Hosp., Istanbul, Turkey, Dept. of Neurology, Celal Bayar University Hosp., Manisa, Turkey, Dept. of Neurology, Gaziantep University Hosp., Gaziantep, Turkey, Dept. of Neurology, Bakirkoy, Sadi Konuk Ed. Res. Hosp., Istanbul, Turkey, Dept. of Neurology, Dicle University Hosp., Diyarbakir, Turkey, Dept. of Neurology, Suleyman Demirel University Hosp., Isparta, Turkey, Dept. of Neurology, Tepecik Ed. Res. Hosp., Izmir, Turkey, Dept of Neurology, Atatürk Ed. Res. Hosp., Izmir, Turkey, Meram Medical Faculty, Dept. of Neurology, Necmettin Erbakan University, Konya, Turkey, Dept. of Neurology, Fatih Sultan Mehmet Ed. Res. Hosp., Istanbul, Turkey, Dept. of Neurology, Cumhuriyet University Hosp., Sivas, Turkey, Cerrahpasa Medical Faculty, Dept. of Neurology, Istanbul University, Istanbul, Turkey, Dept. of Neurology, Cukurova University Hosp., Adana, Turkey, Dept. of Neurology, Kocaeli University Hosp., Izmit, Turkey, Dept. of Neurology, Namık Kemal University Hosp., Tekirdag, Turkey, Beykent University, Turkey, Çukurova Üniversitesi, Ondokuz Mayıs Üniversitesi, Gokyigit, M.C., Dept. of Neurology, Sisli Hamidiye Etfal Ed. Res. Hosp., Istanbul, Turkey, Beykent University, Turkey -- Ekmekci, H., Dept. of Neurology, Selçuk University Hosp., Konya, Turkey -- Durmus, H., Dept. of Neurology Istanbul, İstanbul Medical Faculty, University of Istanbul, Istanbul, Turkey -- Karlı, N., Dept. of Neurology, Uludağ University Hosp., Bursa, Turkey -- Koseoglu, E., Dept. of Neurology, Erciyes University Hosp., Kayseri, Turkey -- Aysal, F., Medipol University Hosp., Istanbul, Turkey -- Kotan, D., Dept. of Neurology, Sakarya University Hosp., Sakarya, Turkey -- Ali, A., Dept. of Neurology, Sevket Yılmaz Ed. Res. Hosp., Bursa, Turkey -- Koytak, P.K., Dept. of Neurology, Marmara University Hospital, Istanbul, Turkey -- Karasoy, H., Dept. of Neurology, Ege University Hosp., İzmir, Turkey -- Yaman, A., Dept. of Neurology, Antalya Ed. Res. Hosp., Antalya, Turkey -- Sengun, İ.S., Dept. of Neurology, Dokuz Eylül University Hosp., İzmir, Turkey -- Sayin, R., Dept. of Neurology, Yüzüncü Yil University Hospital, Van, Turkey -- Tiftikcioglu, B.I., Tepecik Ed. Res. Hosp., Izmir, Turkey -- Soysal, A., Dept. of Neurology, Bakırkoy Psychiatric and Neurological Hosp., Istanbul, Turkey -- Tutkavul, K., Dept. of Neurology, Haydarpaşa Ed. Res. Hosp., İstanbul, Turkey -- Bayrak, A.O., Dept. of Neurology, Ondokuz Mayıs University Hosp., Samsun, Turkey -- Kısabay, A., Dept. of Neurology Manisa, Celal Bayar University Hosp., Manisa, Turkey -- Elci, M.A., Dept. of Neurology Gaziantep, Gaziantep University Hosp., Gaziantep, Turkey -- Yayla, V., Dept. of Neurology, Bakırkoy Sadi Konuk Ed. Res. Hosp., Istanbul, Turkey -- Yılmaz, İ.A., Dept. of Neurology, Mersin University Hosp., Mersin, Turkey -- Ozdamar, S.E., Dept. of Neurology, Hacettepe University Hosp., Ankara, Turkey -- Erdogan, C., Dept. of Neurology, Pamukkale University Hosp., Denizli, Turkey -- Tasdemir, N., Dept. of Neurology, Dicle University Hosp., Diyarbakır, Turkey -- Serdaroglu Oflazer, P., Dept. of Neurology Istanbul, İstanbul Medical Faculty, University of Istanbul, Istanbul, Turkey -- Deymeer, F., Istanbul Medical Faculty, Dept. of Neurology, University of Istanbul, Istanbul, Turkey -- Parman, Y., Istanbul Medical Faculty, Dept. of Neurology, University of Istanbul, Istanbul, Turkey -- Kendirci, M., Dept. of Neurology, Erciyes University Hosp., Kayseri, Turkey -- Sayan, S., Dept. of Neurology, Sakarya University Hosp., Sakarya, Turkey -- Celebi, L.G., Dept. of Neurology, Sisli Hamidiye Etfal Ed. Res. Hosp., Istanbul, Turkey -- Uluç, K., Dept. of Neurology, Marmara University Hospital, Istanbul, Turkey -- Tanrıdağ, T., Dept. of Neurology, Marmara University Hospital, Istanbul, Turkey -- Yuceyar, N., Dept. of Neurology, Ege University Hosp., Izmir, Turkey -- Ekmekci, O., Dept. of Neurology, Ege University Hosp., Izmir, Turkey -- Colakoglu, B.D., Dept. of Neurology, Dokuz Eylul University Hosp., Izmir, Turkey -- Ozturk, S., Dept. of Neurology, Selcuk University Hospital, Konya, Turkey -- Tireli, H., Dept. of Neurology, Haydarpasa Ed. Res. Hosp., Istanbul, Turkey -- Selcuki, D., Dept. of Neurology, Celal Bayar University Hosp., Manisa, Turkey -- Neyal, A.M., Dept. of Neurology, Gaziantep University Hosp., Gaziantep, Turkey -- Kayran, Y., Dept. of Neurology, Bakirkoy, Sadi Konuk Ed. Res. Hosp., Istanbul, Turkey -- Aluclu, M.U., Dept. of Neurology, Dicle University Hosp., Diyarbakir, Turkey -- Koyuncuoglu, H.R., Dept. of Neurology, Suleyman Demirel University Hosp., Isparta, Turkey -- Tokucoglu, F., Dept. of Neurology, Tepecik Ed. Res. Hosp., Izmir, Turkey -- Secil, Y., Dept of Neurology, Atatürk Ed. Res. Hosp., Izmir, Turkey -- Guney, F., Meram Medical Faculty, Dept. of Neurology, Necmettin Erbakan University, Konya, Turkey -- Gozke, E., Dept. of Neurology, Fatih Sultan Mehmet Ed. Res. Hosp., Istanbul, Turkey -- Balaban, H., Dept. of Neurology, Cumhuriyet University Hosp., Sivas, Turkey -- Akalın, M.A., Cerrahpasa Medical Faculty, Dept. of Neurology, Istanbul University, Istanbul, Turkey -- Koc, A.F., Dept. of Neurology, Cukurova University Hosp., Adana, Turkey -- Mulayim, S., Dept. of Neurology, Kocaeli University Hosp., Izmit, Turkey -- Turgut, N., Dept. of Neurology, Namık Kemal University Hosp., Tekirdag, Turkey -- Turkish Study Group for Late Onset Pompe Disease, Gokyigit, MC, Ekmekci, H, Durmus, H, Karll, N, Koseoglu, E, Aysal, F, Kotan, D, Ali, A, Koytak, PK, Karasoy, H, Yaman, A, Sengun, IS, Sayin, R, Tiftikcioglu, BI, Soysal, A, Tutkavul, K, Bayrak, AO, Kisabay, A, Elci, MA, Yayla, V, Yilmaz, IA, Ozdamar, SE, Erdogan, C, Tasdemir, N, Oflazer, PS, Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü, and Kotan Dündar, Dilcan
- Subjects
0301 basic medicine ,glycogen storage disease type 2 ,Pediatrics ,enzyme assay ,Databases, Factual ,Turkey ,Turkey (republic) ,0302 clinical medicine ,data base ,Glycogen storage disease type II ,Prevalence ,Mass Screening ,creatine kinase blood level ,Registries ,Age of Onset ,Genetics (clinical) ,medicine.diagnostic_test ,Glycogen Storage Disease Type II ,adult ,genetic screening ,Creatine Kinase/blood ,Glycogen Storage Disease Type II/blood/diagnosis/*epidemiology ,Humans ,Turkey/epidemiology ,Dried blood spot ,aged ,female ,Neurology ,priority journal ,LOPD ,Acid alpha-glucosidase ,histopathology ,disease registry ,medicine.symptom ,myopathy ,mutational analysis ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Registry ,electrodiagnosis ,Late onset ,Article ,enzyme blood level ,03 medical and health sciences ,male ,respiratory distress ,medicine ,controlled study ,human ,Myopathy ,Acid alpha glucosidase ,Mass screening ,Genetic testing ,muscle weakness ,business.industry ,creatine kinase ,screening ,glucan 1,4 alpha glucosidase ,medicine.disease ,major clinical study ,human tissue ,late onset disorder ,Limb girdle muscle weakness ,030104 developmental biology ,multicenter study ,Pediatrics, Perinatology and Child Health ,Neurosciences & Neurology ,Neurology (clinical) ,Age of onset ,business ,030217 neurology & neurosurgery - Abstract
WOS: 000430763800010 PubMed ID: 29395671 The aim of this study was to search for the frequency of late onset Pompe disease (LOPD) among patients who had a myopathy with unknown diagnosis registered in the pre-diagnostic part of a novel registry for LOPD within a collaborative study of neurologists working throughout Turkey. Included in the study were 350 patients older than 18 years who have a myopathic syndrome without a proven diagnosis by serum creatine kinase (CK) levels, electrodiagnostic studies, and/or muscle pathology, and/or genetic tests for myopathies other than LOPD. Acid alpha glucosidase (GAA) in dried blood spot was measured in each patient at two different university laboratories. LOPD was confirmed by mutation analysis in patients with decreased GAA levels from either both or one of the laboratories. Pre-diagnostic data, recorded by 45 investigators from 32 centers on 350 patients revealed low GAA levels in a total of 21 patients; from both laboratories in 6 and from either one of the laboratories in 15. Among them, genetic testing proved LOPD in 3 of 6 patients and 1 of 15 patients with decreased GAA levels from both or one of the laboratories respectively. Registry was transferred to Turkish Neurological Association after completion of the study for possible future use and development. Our collaborative study enabled collection of a considerable amount of data on the registry in a short time. GAA levels by dried blood spot even from two different laboratories in the same patient may not prove LOPD. LOPD seemed to be rarer in Turkey than in Europe. (C) 2017 Elsevier B.V. All rights reserved.
- Published
- 2018
34. Investigation of effects of transferrin-conjugated gold nanoparticles on hippocampal neuronal activity and anxiety behavior in mice
- Author
-
Yavuz Yavuz, Gamze Yesilay, Bilge Guvenc Tuna, Akif Maharramov, Mustafa Culha, Cihan Suleyman Erdogan, Gunseli Ayse Garip, Bayram Yilmaz, and Yavuz Y., Yesilay G., Guvenc Tuna B., Maharramov A., Culha M., Erdogan C. S., GARİP G. A., Yilmaz B.
- Subjects
Locomotor activity ,INVOLVEMENT ,STRESS ,DISORDERS ,Clinical Biochemistry ,Temel Tıp Bilimleri ,Histoloji-Embriyoloji ,Life Sciences (LIFE) ,Molecular Biology and Genetics ,CELL BIOLOGY ,Sağlık Bilimleri ,Fundamental Medical Sciences ,THERAPY ,DELIVERY ,BİYOKİMYA VE MOLEKÜLER BİYOLOJİ ,BIODISTRIBUTION ,Yaşam Bilimleri ,Health Sciences ,Gold nanoparticles ,Cytogenetic ,Molecular Biology ,Moleküler Biyoloji ve Genetik ,OXIDE NANOPARTICLES ,CHANNELS ,Hücre Biyolojisi ,Moleküler Biyoloji ,Temel Bilimler ,Histology and Embryology ,Transferrin ,Life Sciences ,Action potential ,Anxiety-like behaviors ,General Medicine ,HÜCRE BİYOLOJİSİ ,Tıp ,MOLECULAR BIOLOGY & GENETICS ,Electrophysiology ,Klinik Biyokimya ,ANTIBODY ,Yaşam Bilimleri (LIFE) ,NEUROTOXICITY ,Medicine ,Natural Sciences ,BIOCHEMISTRY & MOLECULAR BIOLOGY ,Sitogenetik - Abstract
Gold nanoparticles (GNPs) have been widely used in medicine such as imaging, drug delivery and therapeutics due to their multifunctional properties. Alterations in neuronal function may contribute to various neurological diseases. Transferrin plays a primary role in iron transportation and delivery and has recently been utilized for drug delivery to the brain. We have investigated effects of transferrin-conjugated GNPs (Tf-GNPs) on anxiety and locomotor behavior in vivo and also hippocampal neuronal activity ex vivo. Electrophysiological effects of Tf-GNP on hippocampal neurons were determined by patch clamp method. Fifteen male young adult C57BL/6 mice were randomly divided into three groups as control (200 µL PBS), GNP (bare GNP; 2.2 μg/g in PBS) and Tf-GNPs (2.2 μg/g Tf-GNP). Animals intraperitoneally received the respective treatments for seven consecutive days and were subjected to elevated plus maze (EPM) and open field tests (OFT). Ex vivo, firing frequency of the neurons significantly increased by GNP treatment (p < 0.001). In vivo, animals in Tf-GNP group showed significantly longer distance in open arms but significantly lower number of entries to the open arms in EPM (p < 0.05). Mice received bare GNPs had significantly higher locomotor activity in OFT (p < 0.05), while Tf-GNP did not alter the locomotor activity significantly (p = 0.051). Animals in Tf-GNP group spent significantly longer time in the peripheral zone in OFT (p < 0.05). The present findings have shown that Tf-GNP induces anxiety-like behavior without altering spontaneous firing rate of hippocampal neurons. We suggest that neurobiological effects of Tf-GNP should be pre-determined before using in medical applications.
- Published
- 2022
35. Role of strontium substitution in spray drying of hydroxyapatite: A comparative study on physical properties
- Author
-
Fatih Üstel, Fatih Erdem Bastan, Garip Erdogan, Bastan, FE, Erdogan, C, Ustel, F, Sakarya Üniversitesi/Mühendislik Fakültesi/Metalurji Ve Malzeme Mühendisliği Bölümü, and Üstel, Fatih
- Subjects
Marketing ,Strontium ,Materials science ,chemistry ,Chemical engineering ,Spray drying ,Materials Science ,Materials Chemistry ,Ceramics and Composites ,chemistry.chemical_element ,Condensed Matter Physics - Abstract
Spray drying (SD) has the ability to tailor granule size and morphology, thus, it is used for producing hydroxyapatite (HA) granules. Recently, Sr functionalized HA (SrHA) has been recommended owing to its improved biological properties. The aim of this article was to produce SrHA granules with the combination of nanoparticle synthesis and spray-drying. The effects of substitution on the physical properties of SrHA nanoparticles and spray-dried granules were investigated. TEM analyzes revealed that Sr substitution reduced the mean size of HA nanoparticles from 4.59 nm to 2.31 nm. Besides, Sr substitution increased the viscosity of the prepared slurry for spray drying, which may be attributed to the smaller nanoparticle sizes. The reduced nanoparticle size caused to the agglomeration of the SrHA more than the pure HA nanoparticles. Moreover the 16 mol % Sr substituted HA (16SrHA) slurry were quickly hardened, which hampered the feeding of the slurry to the SD system; eventually the atomizer was blocked. The increase in the viscosity increased the mean granule size of HA from 41.53 mu m to 49.18 mu m. HA and 8SrHA granules presented HA phase dominantly after the heat treatment at 1000 degrees C, while, 16SrHA decomposed to TCP according to RAMAN and XRD investigations.
- Published
- 2019
- Full Text
- View/download PDF
36. Single-nucleus chromatin accessibility and transcriptomic map of breast tissues of women of diverse genetic ancestry.
- Author
-
Bhat-Nakshatri P, Gao H, Khatpe AS, Adebayo AK, McGuire PC, Erdogan C, Chen D, Jiang G, New F, German R, Emmert L, Sandusky G, Storniolo AM, Liu Y, and Nakshatri H
- Subjects
- Adult, Female, Humans, Middle Aged, Breast cytology, Epithelial Cells metabolism, Fibroblasts metabolism, Gene Expression Profiling, Gene Regulatory Networks, Hepatocyte Nuclear Factor 3-alpha genetics, Hepatocyte Nuclear Factor 3-alpha metabolism, Single-Cell Analysis, Ethnicity genetics, Chromatin genetics, Chromatin metabolism, Transcriptome genetics
- Abstract
Single-nucleus analysis allows robust cell-type classification and helps to establish relationships between chromatin accessibility and cell-type-specific gene expression. Here, using samples from 92 women of several genetic ancestries, we developed a comprehensive chromatin accessibility and gene expression atlas of the breast tissue. Integrated analysis revealed ten distinct cell types, including three major epithelial subtypes (luminal hormone sensing, luminal adaptive secretory precursor (LASP) and basal-myoepithelial), two endothelial and adipocyte subtypes, fibroblasts, T cells, and macrophages. In addition to the known cell identity genes FOXA1 (luminal hormone sensing), EHF and ELF5 (LASP), TP63 and KRT14 (basal-myoepithelial), epithelial subtypes displayed several uncharacterized markers and inferred gene regulatory networks. By integrating breast epithelial cell gene expression signatures with spatial transcriptomics, we identified gene expression and signaling differences between lobular and ductal epithelial cells and age-associated changes in signaling networks. LASP cells and fibroblasts showed genetic ancestry-dependent variability. An estrogen receptor-positive subpopulation of LASP cells with alveolar progenitor cell state was enriched in women of Indigenous American ancestry. Fibroblasts from breast tissues of women of African and European ancestry clustered differently, with accompanying gene expression differences. Collectively, these data provide a vital resource for further exploring genetic ancestry-dependent variability in healthy breast biology., Competing Interests: Competing interests: The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
37. A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer.
- Author
-
Omar M, Harrell JC, Tamimi R, Marchionni L, Erdogan C, Nakshatri H, and Ince TA
- Subjects
- Humans, Female, Prognosis, Gene Expression Regulation, Neoplastic, Gene Expression Profiling, Kaplan-Meier Estimate, Transcriptome, Breast Neoplasms genetics, Breast Neoplasms pathology, Breast Neoplasms mortality, Breast Neoplasms metabolism, Receptors, Calcitriol genetics, Receptors, Calcitriol metabolism, Receptors, Estrogen metabolism, Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Receptors, Androgen genetics, Receptors, Androgen metabolism
- Abstract
Background: Despite evidence indicating the dominance of cell-of-origin signatures in molecular tumor patterns, translating these genome-wide patterns into actionable insights has been challenging. This study introduces breast cancer cell-of-origin signatures that offer significant prognostic value across all breast cancer subtypes and various clinical cohorts, compared to previously developed genomic signatures., Methods: We previously reported that triple hormone receptor (THR) co-expression patterns of androgen (AR), estrogen (ER), and vitamin D (VDR) receptors are maintained at the protein level in human breast cancers. Here, we developed corresponding mRNA signatures (THR-50 and THR-70) based on these patterns to categorize breast tumors by their THR expression levels. The THR mRNA signatures were evaluated across 56 breast cancer datasets (5040 patients) using Kaplan-Meier survival analysis, Cox proportional hazard regression, and unsupervised clustering., Results: The THR signatures effectively predict both overall and progression-free survival across all evaluated datasets, independent of subtype, grade, or treatment status, suggesting improvement over existing prognostic signatures. Furthermore, they delineate three distinct ER-positive breast cancer subtypes with significant survival in differences-expanding on the conventional two subtypes. Additionally, coupling THR-70 with an immune signature identifies a predominantly ER-negative breast cancer subgroup with a highly favorable prognosis, comparable to ER-positive cases, as well as an ER-negative subgroup with notably poor outcome, characterized by a 15-fold shorter survival., Conclusions: The THR cell-of-origin signature introduces a novel dimension to breast cancer biology, potentially serving as a robust foundation for integrating additional prognostic biomarkers. These signatures offer utility as a prognostic index for stratifying existing breast cancer subtypes and for de novo classification of breast cancer cases. Moreover, THR signatures may also hold promise in predicting hormone treatment responses targeting AR and/or VDR., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
38. Oxygen tension-dependent variability in the cancer cell kinome impacts signaling pathways and response to targeted therapies.
- Author
-
Adebayo AK, Bhat-Nakshatri P, Davis C, Angus SP, Erdogan C, Gao H, Green N, Kumar B, Liu Y, and Nakshatri H
- Abstract
Most cells in solid tumors are exposed to oxygen levels between 0.5% and 5%. We developed an approach that allows collection, processing, and evaluation of cancer and non-cancer cells under physioxia, while preventing exposure to ambient air. This aided comparison of baseline and drug-induced changes in signaling pathways under physioxia and ambient oxygen. Using tumor cells from transgenic models of breast cancer and cells from breast tissues of clinically breast cancer-free women, we demonstrate oxygen-dependent differences in cell preference for epidermal growth factor receptor (EGFR) or platelet-derived growth factor receptor beta (PDGFRβ) signaling. Physioxia caused PDGFRβ-mediated activation of AKT and extracellular regulated kinase (ERK) that reduced sensitivity to EGFR and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) inhibition and maintained PDGFRβ+ epithelial-mesenchymal hybrid cells with potential cancer stem cell (CSC) properties. Cells in ambient air displayed differential EGFR activation and were more sensitive to targeted therapies. Our data emphasize the importance of oxygen considerations in preclinical cancer research to identify effective drug targets and develop combination therapy regimens., Competing Interests: The authors declare no competing interests., (© 2024 The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
39. Bioinformatics analysis of the potentially functional circRNA-miRNA-mRNA network in breast cancer.
- Author
-
Erdogan C, Suer I, Kaya M, Ozturk S, Aydin N, and Kurt Z
- Subjects
- Humans, Female, RNA, Circular genetics, Computational Biology, Biomarkers, Gene Regulatory Networks, Breast Neoplasms genetics, MicroRNAs genetics
- Abstract
Breast cancer (BC) is the most common cancer among women with high morbidity and mortality. Therefore, new research is still needed for biomarker detection. GSE101124 and GSE182471 datasets were obtained from the Gene Expression Omnibus (GEO) database to evaluate differentially expressed circular RNAs (circRNAs). The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) databases were used to identify the significantly dysregulated microRNAs (miRNAs) and genes considering the Prediction Analysis of Microarray classification (PAM50). The circRNA-miRNA-mRNA relationship was investigated using the Cancer-Specific CircRNA, miRDB, miRTarBase, and miRWalk databases. The circRNA-miRNA-mRNA regulatory network was annotated using Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database. The protein-protein interaction network was constructed by the STRING database and visualized by the Cytoscape tool. Then, raw miRNA data and genes were filtered using some selection criteria according to a specific expression level in PAM50 subgroups. A bottleneck method was utilized to obtain highly interacted hub genes using cytoHubba Cytoscape plugin. The Disease-Free Survival and Overall Survival analysis were performed for these hub genes, which are detected within the miRNA and circRNA axis in our study. We identified three circRNAs, three miRNAs, and eighteen candidate target genes that may play an important role in BC. In addition, it has been determined that these molecules can be useful in the classification of BC, especially in determining the basal-like breast cancer (BLBC) subtype. We conclude that hsa_circ_0000515/miR-486-5p/SDC1 axis may be an important biomarker candidate in distinguishing patients in the BLBC subgroup of BC., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Erdogan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
40. Sex Differences under Vitamin D Supplementation in an Animal Model of Progressive Multiple Sclerosis.
- Author
-
Haindl MT, Üçal M, Tafrali C, Wonisch W, Erdogan C, Nowakowska M, Adzemovic MZ, Enzinger C, Khalil M, and Hochmeister S
- Subjects
- Humans, Female, Male, Rats, Animals, Sex Characteristics, Vitamin D, Vitamins, Dietary Supplements, Models, Animal, Gonadal Steroid Hormones, Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive
- Abstract
A central role for vitamin D (VD) in immune modulation has recently been recognized linking VD insufficiency to autoimmune disorders that commonly exhibit sex-associated differences. Similar to other autoimmune diseases, there is a higher incidence of multiple sclerosis (MS) in women, but a poorer prognosis in men, often characterized by a more rapid progression. Although sex hormones are most likely involved, this phenomenon is still poorly understood. Oxidative stress, modulated by VD serum levels as well as sex hormones, may act as a contributing factor to demyelination and axonal damage in both MS and the corresponding preclinical models. In this study, we analyzed sex-associated differences and VD effects utilizing an animal model that recapitulates histopathological features of the progressive MS phase (PMS). In contrast to relapsing-remitting MS (RRMS), PMS has been poorly investigated in this context. Male ( n = 50) and female ( n = 46) Dark Agouti rats received either VD (400 IU per week; VD
+ ) or standard rodent food without extra VD (VD- ) from weaning onwards. Myelination, microglial activation, apoptotic cell death and neuronal viability were assessed using immunohistochemical markers in brain tissue. Additionally, we also used two different histological markers against oxidized lipids along with colorimetric methods to measure protective polyphenols (PP) and total antioxidative capacity (TAC) in serum. Neurofilament light chain serum levels (sNfL) were analyzed using single-molecule array (SIMOA) analysis. We found significant differences between female and male animals. Female rats exhibited a better TAC and higher amounts of PP. Additionally, females showed higher myelin preservation, lower microglial activation and better neuronal survival while showing more apoptotic cells than male rats. We even found a delay in reaching the peak of the disease in females. Overall, both sexes benefitted from VD supplementation, represented by significantly less cortical, neuroaxonal and oxidative damage. Unexpectedly, male rats had an even higher overall benefit, most likely due to differences in oxidative capacity and defense systems.- Published
- 2024
- Full Text
- View/download PDF
41. Signaling Pathway Alterations Driven by BRCA1 and BRCA2 Germline Mutations are Sufficient to Initiate Breast Tumorigenesis by the PIK3CAH1047R Oncogene.
- Author
-
Bhat-Nakshatri P, Khatpe AS, Chen D, Batic K, Mang H, Herodotou C, McGuire PC, Xuei X, Erdogan C, Gao H, Liu Y, Sandusky G, Storniolo AM, and Nakshatri H
- Subjects
- Animals, Mice, BRCA2 Protein genetics, Nuclear Proteins genetics, Transcription Factors genetics, Proto-Oncogene Proteins c-myc genetics, Signal Transduction genetics, Oncogenes, Carcinogenesis genetics, BRCA1 Protein genetics, Germ-Line Mutation
- Abstract
Single-cell transcriptomics studies have begun to identify breast epithelial cell and stromal cell specific transcriptome differences between BRCA1/2 mutation carriers and non-carriers. We generated a single-cell transcriptome atlas of breast tissues from BRCA1, BRCA2 mutation carriers and compared this single-cell atlas of mutation carriers with our previously described single-cell breast atlas of healthy non-carriers. We observed that BRCA1 but not BRCA2 mutations altered the ratio between basal (basal-myoepithelial), luminal progenitor (luminal adaptive secretory precursor, LASP), and mature luminal (luminal hormone sensing) cells in breast tissues. A unique subcluster of cells within LASP cells is underrepresented in case of BRCA1 and BRCA2 mutation carriers compared with non-carriers. Both BRCA1 and BRCA2 mutations specifically altered transcriptomes in epithelial cells which are an integral part of NFκB, LARP1, and MYC signaling. Signaling pathway alterations in epithelial cells unique to BRCA1 mutations included STAT3, BRD4, SMARCA4, HIF2A/EPAS1, and Inhibin A signaling. BRCA2 mutations were associated with upregulation of IL6, PDK1, FOXO3, and TNFSF11 signaling. These signaling pathway alterations are sufficient to alter sensitivity of BRCA1/BRCA2-mutant breast epithelial cells to transformation as epithelial cells from BRCA1 mutation carriers overexpressing hTERT + PIK3CAH1047R generated adenocarcinomas, whereas similarly modified mutant BRCA2 cells generated basal carcinomas in NSG mice. Thus, our studies provide a high-resolution transcriptome atlas of breast epithelial cells of BRCA1 and BRCA2 mutation carriers and reveal their susceptibility to PIK3CA mutation-driven transformation., Significance: This study provides a single-cell atlas of breast tissues of BRCA1/2 mutation carriers and demonstrates that aberrant signaling due to BRCA1/2 mutations is sufficient to initiate breast cancer by mutant PIK3CA., (© 2024 The Authors; Published by the American Association for Cancer Research.)
- Published
- 2024
- Full Text
- View/download PDF
42. Postoperative recovery scores and pain management: a comparison of modified thoracolumbar interfascial plane block and quadratus lumborum block for lumbar disc herniation.
- Author
-
Alver S, Ciftci B, Celik EC, Sargolzaeimoghaddam M, Cetinkal A, Erdogan C, and Ahiskalioglu A
- Subjects
- Humans, Anesthetics, Local therapeutic use, Pain, Postoperative drug therapy, Pain, Postoperative prevention & control, Postoperative Period, Ultrasonography, Interventional, Analgesics, Opioid, Intervertebral Disc Displacement surgery, Nerve Block
- Abstract
Purpose: In this prospective, randomized study, we aimed to compare the global recovery scores and postoperative pain management between US-guided mTLIP block versus QLB after lumbar spine surgery., Methods: 60 patients with ASA score I-II planned for microendoscopic discectomy under general anesthesia were included. We allocated the patients into two groups: the QLB group (n = 30) or the mTLIP group (n = 30). QLB and mTLIP was performed with 30 ml 0.25% bupivacaine in the groups. Paracetamol 1 g IV 3 × 1 was ordered to the patients at the postoperative period. If the NRS score was ≥ 4, 1 mg/kg tramadol IV was administered as rescue analgesia., Results: There was a significant between-group difference in the mean global QoR-40 scores 24 h postsurgery. Both the static and dynamic NRS scores were significantly lower in the postoperative 1-16 h period in the mTLIP group. There was no significant between-group difference in the NRS scores 24 h postsurgery. There was no significant between-group difference in postoperative rescue analgesia consumption. However, the need for rescue analgesia was lower in the postoperative first 5 h in the mTLIP group, and survival probability was higher in the mTLIP group according to Kaplan-Meier survival analysis. There was no significant difference between the groups in the rate of adverse events., Conclusion: mTLIP provided superior analgesia compared to posterior QLB. The QoR-40 scores in the mTLIP group were higher than those in the QLB group., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
43. Maxillomandibular Advancement Efficacy in Obstructive Sleep Apnea Patients With Class 2 Versus 3 Dentofacial Deformity.
- Author
-
Abdelwahab M, Taheri N, Eltahir L, Erdogan C, Lee K, and Liu SY
- Subjects
- Humans, Retrospective Studies, Sleep, Oxygen, Treatment Outcome, Dentofacial Deformities surgery, Mandibular Advancement, Sleep Apnea, Obstructive surgery
- Abstract
Objective: To compare the efficacy of maxillomandibular advancement (MMA) for patients with obstructive sleep apnea (OSA) with class 2 versus 3 dentofacial deformities (DFDs)., Study Design: Retrospective chart review., Setting: Tertiary sleep surgery center., Methods: Patients with OSA and DFD class 2 versus 3 undergoing MMA at Stanford Sleep Surgery between 2014 and 2021 were matched by preoperative body mass index (BMI), age, and sex. Postoperative outcome was compared with polysomnography measures and patient-reported outcome measures (PROMs)., Results: Twenty-eight matched subjects, 14 in each deformity group were identified and assessed. The mean age (standard deviation) was 34.29 (10.21) and 33.86 (10.23) for classes 2 and 3, respectively. The apnea-hypopnea index (AHI) decreased from 43.42 (28.30) to 9.6 (5.29) (p < .001) and 37.17 (35.77) to 11.81 (15.74) (p = .042) in class 2 and 3 subjects, respectively. The oxygen desaturation index (ODI) changed from 30.48 (24.02) to 6.88 (3.39) (p = .024) and 11.43 (11.40) to 5.44 (7.96) (p = .85) in class 2 and 3 subjects, respectively. The Epworth sleepiness scale changed from 8.93 (5.28) to 3.91 (2.70) (p = .018) and 10.23 (4.38) to 4.22 (3.07) (p = .006) in class 2 and 3 subjects, respectively., Conclusion: Among age, sex, and BMI-matched subjects, MMA is equally effective in both dentofacial class 2 and 3 groups, both objectively and subjectively. Preoperatively, dentofacial class 2 patients with OSA presented with the more severe disease with higher AHI and ODI. Dentofacial class 3 patients with OSA may require additional attention to improve nasal function outcomes., (© 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation.)
- Published
- 2023
- Full Text
- View/download PDF
44. Multimodality imaging findings of infected endometriomas: "T1 signal reversal" as a potential diagnostic sign?
- Author
-
Onder O, Dilek I, Erdogan C, Toker Onder I, Arik E, Atasoy G, Yazkan Erdogan K, and Ali Algan C
- Abstract
Endometrioma superinfection is a rare clinical entity that may cause diagnostic confusion and can be complicated by rupture, peritonitis, sepsis, and even death. Therefore, early diagnosis is crucial for appropriate patient management. Since clinical findings can be mild or nonspecific, radiological imaging is frequently used for diagnostic purposes. From a radiological perspective, it can be challenging to distinguish the presence of infection in an endometrioma. Complex cyst structure, wall thickening, increased peripheral vascularization, nondependent air bubbles, and surrounding inflammatory changes have been reported as potential US and CT findings suggestive of superinfection. On the other hand, there is a gap in the literature regarding MRI findings. To the best of our knowledge, this is the first case report in the literature to discuss MRI findings and temporal evolution of infected endometriomas. In this case report, we aim to present a patient with bilateral infected endometriomas at different stages, and to discuss the multimodality imaging findings, focusing specifically on the MRI. We defined 2 new MRI findings that may indicate the presence of superinfection in the early period. The first one was the "T1 signal reversal" seen in bilateral endometriomas. The second one, "progressive disappearance of T2 shading," was observed only in the right-sided lesion. These nonenhancing signal changes accompanied by increased lesion sizes during MRI follow-up were thought to represent a transition from blood to pus, and the percutaneous drainage of the right-sided endometrioma microbiologically confirmed our suspicion. In conclusion, MRI can be helpful in the early diagnosis of infected endometrioma due to its high soft tissue resolution. Percutaneous treatment may contribute to patient management as an alternative to surgical drainage., (© 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.)
- Published
- 2023
- Full Text
- View/download PDF
45. Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation.
- Author
-
Mutlu YG, Aydin BB, Erdogan C, Kizilaslan D, Beköz HS, Gemici A, Kaynar L, and Sevindik ÖG
- Abstract
Introduction: To identify new clinical and biologic parameters associated with short-term survival in allogeneic or autologous hematopoietic stem cell transplantation (HSCT) patients who were admitted to the intensive care unit (ICU) during their post-transplant period., Materials and Methods: 40 patients who were admitted to the ICU in our center during their post-transplant period were evaluated retrospectively between Jan 2014 - Jun 2021. Baseline patient characteristics before the transplant, reasons for ICU admissions, laboratory and clinical findings, supportive treatment in ICU and short-term survival were analyzed., Results: We found 8.8% ICU admission rate in all patient group (n = 450). Mortality rate of the patients who were admitted to ICU was 75%. Invasive mechanic ventilation, need for vasopressor, heart rate was significantly different between survivor and non-survivor group (p = 0.001, p = 0.001, p = 0.004). Elevated INR was associated with poor survival on ICU (p = 0.033). APACHE II score was an independent predictor of ICU mortality (p = 0.045)., Conclusion: Despite the recent advances in transplant conditioning protocols, prophylaxis strategies and improvements of management in ICU, overall survival for HSCT patients in ICU is still poor. In this study INR level was described as a new prognostic factor in ICU for first time in the literature., Competing Interests: Conflict of interestAll authors declare no conflict of interest that may have influences either the conduct or the presentation of the research., (© The Author(s), under exclusive licence to Indian Society of Hematology and Blood Transfusion 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)
- Published
- 2023
- Full Text
- View/download PDF
46. T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy.
- Author
-
Frank ML, Lu K, Erdogan C, Han Y, Hu J, Wang T, Heymach JV, Zhang J, and Reuben A
- Subjects
- Humans, T-Lymphocytes, Immunotherapy methods, High-Throughput Nucleotide Sequencing methods, Receptors, Antigen, T-Cell genetics, Neoplasms genetics, Neoplasms therapy
- Abstract
T cells are integral components of the adaptive immune system, and their responses are mediated by unique T-cell receptors (TCR) that recognize specific antigens from a variety of biological contexts. As a result, analyzing the T-cell repertoire offers a better understanding of immune responses and of diseases like cancer. Next-generation sequencing technologies have greatly enabled the high-throughput analysis of the TCR repertoire. On the basis of our extensive experience in the field from the past decade, we provide an overview of TCR sequencing, from the initial library preparation steps to sequencing and analysis methods and finally to functional validation techniques. With regards to data analysis, we detail important TCR repertoire metrics and present several computational tools for predicting antigen specificity. Finally, we highlight important applications of TCR sequencing and repertoire analysis to understanding tumor biology and developing cancer immunotherapies., (©2022 The Authors; Published by the American Association for Cancer Research.)
- Published
- 2023
- Full Text
- View/download PDF
47. The efficacy of ultrasound-guided anterior quadratus lumborum block for pain management following lumbar spinal surgery: a randomized controlled trial.
- Author
-
Alver S, Bahadir C, Tahta AC, Cetinkal A, Gölboyu BE, Erdogan C, and Ekinci M
- Subjects
- Humans, Anesthetics, Local, Pain, Postoperative etiology, Ultrasonography, Interventional, Analgesics, Opioid, Pain Management adverse effects, Nerve Block adverse effects
- Abstract
Background: Quadratus lumborum block (QLB) is a fascial plane block. There is no randomized study on the efficacy of QLB for lumbar surgery. We evaluated the efficacy of QLB for postoperative pain management and patient satisfaction after lumbar disc herniation surgery (LDHS)., Methods: Sixty patients with ASA score I-II planned for LDHS under general anesthesia were included. We allocated the patients into two groups: the QLB group (n = 30) or the control group (n = 30). QLB was performed with 30 ml 0.25% bupivacaine in the QLB group. Paracetamol 1 g IV 3 × 1 was ordered to the patients at the postoperative period. If the NRS score was ≥ 4, 1 mg/ kg tramadol IV was administered as rescue analgesia., Results: There was a reduction in the median static NRS at 0 h and 2 h with QLB compared to the control group (p < 0.05). There was no difference in the resting NRS at any other time point up to 24 h. The median dynamic NRS was significantly lower at 0, 2, 4, 8, and 16 h in the QLB group (p < 0.05). The need for rescue analgesia was significantly lower in the QLB group. The incidence of nausea was significantly higher in the control group. The postoperative patient satisfaction was significantly higher in the QLB group (p < 0.05)., Conclusion: We found that the QLB is effective for pain control following LDHS., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
48. Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study.
- Author
-
Buetti N, Tabah A, Loiodice A, Ruckly S, Aslan AT, Montrucchio G, Cortegiani A, Saltoglu N, Kayaaslan B, Aksoy F, Murat A, Akdoğan Ö, Saracoglu KT, Erdogan C, Leone M, Ferrer R, Paiva JA, Hayashi Y, Ramanan M, Conway Morris A, Barbier F, and Timsit JF
- Subjects
- Aged, Humans, Male, Cohort Studies, Critical Illness epidemiology, Intensive Care Units, COVID-19 epidemiology, Cross Infection epidemiology, Sepsis epidemiology
- Abstract
Background: The study aimed to describe the epidemiology and outcomes of hospital-acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically ill patients., Methods: We used data from the Eurobact II study, a prospective observational multicontinental cohort study on HABSI treated in ICU. For the current analysis, we selected centers that included both COVID-19 and non-COVID-19 critically ill patients. We performed descriptive statistics between COVID-19 and non-COVID-19 in terms of patients' characteristics, source of infection and microorganism distribution. We studied the association between COVID-19 status and mortality using multivariable fragility Cox models., Results: A total of 53 centers from 19 countries over the 5 continents were eligible. Overall, 829 patients (median age 65 years [IQR 55; 74]; male, n = 538 [64.9%]) were treated for a HABSI. Included patients comprised 252 (30.4%) COVID-19 and 577 (69.6%) non-COVID-19 patients. The time interval between hospital admission and HABSI was similar between both groups. Respiratory sources (40.1 vs. 26.0%, p < 0.0001) and primary HABSI (25.4% vs. 17.2%, p = 0.006) were more frequent in COVID-19 patients. COVID-19 patients had more often enterococcal (20.5% vs. 9%) and Acinetobacter spp. (18.8% vs. 13.6%) HABSIs. Bacteremic COVID-19 patients had an increased mortality hazard ratio (HR) versus non-COVID-19 patients (HR 1.91, 95% CI 1.49-2.45)., Conclusions: We showed that the epidemiology of HABSI differed between COVID-19 and non-COVID-19 patients. Enterococcal HABSI predominated in COVID-19 patients. COVID-19 patients with HABSI had elevated risk of mortality. Trial registration ClinicalTrials.org number NCT03937245 . Registered 3 May 2019., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
49. Correction: Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
- Author
-
Khaliq AM, Erdogan C, Kurt Z, Turgut SS, Grunvald MW, Rand T, Khare S, Borgia JA, Hayden DM, Pappas SG, Govekar HR, Kam AE, Reiser J, Turaga K, Radovich M, Zang Y, Qiu Y, Liu Y, Fishel ML, Turk A, Gupta V, Al-Sabti R, Subramanian J, Kuzel TM, Sadanandam A, Waldron L, Hussain A, Saleem M, El-Rayes B, Salahudeen AA, and Masood A
- Published
- 2022
- Full Text
- View/download PDF
50. Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
- Author
-
Khaliq AM, Erdogan C, Kurt Z, Turgut SS, Grunvald MW, Rand T, Khare S, Borgia JA, Hayden DM, Pappas SG, Govekar HR, Kam AE, Reiser J, Turaga K, Radovich M, Zang Y, Qiu Y, Liu Y, Fishel ML, Turk A, Gupta V, Al-Sabti R, Subramanian J, Kuzel TM, Sadanandam A, Waldron L, Hussain A, Saleem M, El-Rayes B, Salahudeen AA, and Masood A
- Subjects
- Humans, Microsatellite Instability, Transcriptome, Tumor Microenvironment genetics, Colorectal Neoplasms genetics, Colorectal Neoplasms pathology, Complement C1q genetics, Complement C1q therapeutic use
- Abstract
Background: Colorectal cancer (CRC) consensus molecular subtypes (CMS) have different immunological, stromal cell, and clinicopathological characteristics. Single-cell characterization of CMS subtype tumor microenvironments is required to elucidate mechanisms of tumor and stroma cell contributions to pathogenesis which may advance subtype-specific therapeutic development. We interrogate racially diverse human CRC samples and analyze multiple independent external cohorts for a total of 487,829 single cells enabling high-resolution depiction of the cellular diversity and heterogeneity within the tumor and microenvironmental cells., Results: Tumor cells recapitulate individual CMS subgroups yet exhibit significant intratumoral CMS heterogeneity. Both CMS1 microsatellite instability (MSI-H) CRCs and microsatellite stable (MSS) CRC demonstrate similar pathway activations at the tumor epithelial level. However, CD8+ cytotoxic T cell phenotype infiltration in MSI-H CRCs may explain why these tumors respond to immune checkpoint inhibitors. Cellular transcriptomic profiles in CRC exist in a tumor immune stromal continuum in contrast to discrete subtypes proposed by studies utilizing bulk transcriptomics. We note a dichotomy in tumor microenvironments across CMS subgroups exists by which patients with high cancer-associated fibroblasts (CAFs) and C1Q+TAM content exhibit poor outcomes, providing a higher level of personalization and precision than would distinct subtypes. Additionally, we discover CAF subtypes known to be associated with immunotherapy resistance., Conclusions: Distinct CAFs and C1Q+ TAMs are sufficient to explain CMS predictive ability and a simpler signature based on these cellular phenotypes could stratify CRC patient prognosis with greater precision. Therapeutically targeting specific CAF subtypes and C1Q + TAMs may promote immunotherapy responses in CRC patients., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.